Spanish pharma company Exeltis, which markets birth-control pill Slynd, was recently cited by American regulators for a paid Facebook post that omitted side-effect information. The Food and Drug ...
The FDA has torn into Exeltis over a social media sponsored post for birth control pill Slynd, lambasting the drugmaker for leaving out all the risk information, making misleading efficacy claims and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results